The Tennessee Booth is a conglomerate group of Tennessee-based research institutions, economic development groups, and private companies in various sectors. Organizations a part of the booth include: Life Science Tennessee, Vanderbilt University, University of Tennessee Research Foundation, Tennessee Department of Economic Development, Nashville Biosciences, Nashville Area Chamber of Commerce, Launch Tennessee, Knoxville Chamber of Commerce, Helix Biotech, and August Bioservices.
Taiwan Bio Industry Organization
About Association Since its founding in 1989, the Taiwan Bio Industry Organization (Taiwan BIO) has been promoting the interests of its members from industry, the government and academia as well as promoting the development of the biomedical industries and their contribution to Taiwan’s economy and people. The more than 100 organizations and 3,000 individuals that make up Taiwan BIO membership represent the entire life sciences industry spectrum, including from the biotechnology, pharmaceutical, diagnostics, medical devices and materials, agricultural biotechnology, and nutraceuticals sectors. | Since its founding in 1989, the Taiwan Bio Industry Organization (Taiwan BIO) has been promoting the interests of its members from industry, the government and academia as well as promoting the development of the biomedical industries and their contribution to Taiwan’s economy and people. The more than 100 organizations and 3,000 individuals that make up Taiwan BIO membership represent the entire life sciences industry spectrum, including from the biotechnology, pharmaceutical, diagnostics, medical devices and materials, agricultural biotechnology, and nutraceuticals sectors. Promoting the interests of our members Taiwan BIO works tirelessly for the interests of its members. With deep connections to government policy makers at all levels, Taiwan BIO advocates strongly for policies that will lead not only to the continued growth of the industry – both locally and internationally – but also to better opportunities for its members. Taiwan BIO pledges to represent equally all its members whether from Taiwan or abroad. Promoting international exchange and cooperation One of TBIO’s key responsibilities is organizing the annual BIO Asia–Taiwan international conference and exhibition, an annual week-long festival of biotech-themed events held in Taipei. Through this gathering, Taiwan BIO helps facilitate networking, licensing and cooperation opportunities between investors, researchers, biotech companies and other key stakeholders, with the event also playing an important role in improving Taiwan’s visibility within the global biotechnology community. Taiwan BIO also helps organize delegations to attend important overseas events, including a large combined industry-government delegation to the BIO International Convention held annually in North America. Promoting communication between government and industry In addition, Taiwan BIO organizes regular conferences, seminars and meetings inviting key industry leaders and government representatives to address members’ interests and concerns. In this way, Taiwan BIO acts as a bridge connecting the private sector, academia, government, and international interests. Cultivating biotechnology industry talent In 2015 Taiwan BIO helped establish the Bio Industry Academy (BIA), a training organization with a mission to better prepare local talent for employment in Taiwan’s growing biopharmaceutical sector, and to upgrade the industry as a whole. Training topics offered by BIA to date include new drug development, manufacturing processes, industry-related business, finance and management, among others. BIA is currently offering over 300 hours of courses each year and has so far helped prepare more than 200 specialists to high-level placement within this demanding industry. Encouraging outstanding performance and innovation Taiwan BIO organizes the annual Taiwan Bio-Industry Organization Awards, with the awards ceremony coinciding with BIO Asia–Taiwan. Winners are recognized in Outstanding Company of the Year, Emerging Company of the Year, and Innovation of the Year categories. In doing so, Taiwan BIO aims to recognize local achievements and encourage innovation within this important industry, helping facilitate its further growth and the development of the entire biotechnology ecosystem. | Since its founding in 1989, the Taiwan Bio Industry Organization (Taiwan BIO) has been promoting the interests of its members from industry, the government and academia as well as promoting the development of the biomedical industries and their contribution to Taiwan’s economy and people. The more than 100 organizations and 3,000 individuals that make up Taiwan BIO membership represent the entire life sciences industry spectrum, including from the biotechnology, pharmaceutical, diagnostics, medical devices and materials, agricultural biotechnology, and nutraceuticals sectors. Taiwan BIO works tirelessly for the interests of its members. With deep connections to government policy makers at all levels, Taiwan BIO advocates strongly for policies that will lead not only to the continued growth of the industry – both locally and internationally – but also to better opportunities for its members. Taiwan BIO pledges to represent equally all its members whether from Taiwan or abroad. One of TBIO’s key responsibilities is organizing the annual BIO Asia–Taiwan international conference and exhibition, an annual week-long festival of biotech-themed events held in Taipei. Through this gathering, Taiwan BIO helps facilitate networking, licensing and cooperation opportunities between investors, researchers, biotech companies and other key stakeholders, with the event also playing an important role in improving Taiwan’s visibility within the global biotechnology community. Taiwan BIO also helps organize delegations to attend important overseas events, including a large combined industry-government delegation to the BIO International Convention held annually in North America. In addition, Taiwan BIO organizes regular conferences, seminars and meetings inviting key industry leaders and government representatives to address members’ interests and concerns. In this way, Taiwan BIO acts as a bridge connecting the private sector, academia, government, and international interests. In 2015 Taiwan BIO helped establish the Bio Industry Academy (BIA), a training organization with a mission to better prepare local talent for employment in Taiwan’s growing biopharmaceutical sector, and to upgrade the industry as a whole. Training topics offered by BIA to date include new drug development, manufacturing processes, industry-related business, finance and management, among others. BIA is currently offering over 300 hours of courses each year and has so far helped prepare more than 200 specialists to high-level placement within this demanding industry. Taiwan BIO organizes the annual Taiwan Bio-Industry Organization Awards, with the awards ceremony coinciding with BIO Asia–Taiwan. Winners are recognized in Outstanding Company of the Year, Emerging Company of the Year, and Innovation of the Year categories. In doing so, Taiwan BIO aims to recognize local achievements and encourage innovation within this important industry, helping facilitate its further growth and the development of the entire biotechnology ecosystem.
Switzerland Global Enterprise
Switzerland Global Enterprise (S-GE) is the official Swiss organization for export and investment promotion. S-GE supports Swiss SMEs in their international business and helps innovative foreign companies on their way to settling in Switzerland. As a private organization, S-GE has acted on behalf of the Swiss Confederation and cantons since 1927 to ensure strength in the country’s foreign trade and prosperity in Switzerland. | Are you thinking about taking your business to the next level and contributing to innovative, sustainable solutions for the future? Think Switzerland! Consider Switzerland Global Enterprise (S-GE) and our Swiss Business Hubs around the world your partner, with the network, tools and resources needed to make informed location and investment decisions. A leading position in relevant innovation ecosystems, access to talents, partners and markets, a liberal economic system, political stability, an excellent education system and a high standard of living are among the factors that make Switzerland the most competitive business center in the world. Our country adds value to businesses that want to increase scale and impact. Switzerland Global Enterprise is here to help you navigate Switzerland’s business and innovation environment. Our service is free of charge. INFORM We help with your location analysis. We provide you with data and information to get a clear picture of how Switzerland can add value as leading innovation ecosystem, specifically to your needs. This includes information on legal, tax and administrative conditions, the regulatory environment, salary costs and talent. We help you benchmark Switzerland with other countries and regions on your shortlist. VISIT To really experience what working and living in Switzerland feels like, we facilitate managed site visits – in person or virtual – tailored to your interests and industry-specific ecosystem. This gives you the opportunity to engage with local peers and hear how they successfully use Switzerland as base for their business. CONNECT Meet our regional and cantonal partner organizations, talk to industry experts, consult with recruiters and connect with universities and research centers – we happily provide you with contacts and introductions that kick-off and accelerate your growth in Switzerland. YOUR INVESTMENT TEAM ACROSS THE GLOBE In addition to our offices in Switzerland, we have a network of 22 Swiss Business Hubs integrated into the Swiss diplomatic missions abroad. Would you like to know more about what Switzerland has to offer as a business location? Select your regional office and get in touch. | Switzerland Global Enterprise (S-GE) is the official Swiss organization dedicated to export and investment promotion. With a presence in over 130 markets worldwide, S-GE supports Swiss companies in expanding their international footprint and assists innovative foreign companies in establishing operations in Switzerland. At S-GE, we understand the power of connections. Our services are designed to foster meaningful relationships between Swiss companies and international partners, creating a robust network that drives success abroad. One platform to create visibility for the Swiss Biotech Industry is the SWISS Pavilion at the most relevant biotech shows worldwide. It offers a great platform for Swiss companies and organizations to be present in the markets and to connect to the international biotech community. | Grüezi and welcome to Switzerland! Switzerland Global Enterprise (S-GE) is the organizer of the SWISS Pavilion, the official Swiss participation at MD&M West 2026. We offer support and consulting services for export from Switzerland abroad and investing in Switzerland. We proudly state that our stand covers 18 Swiss companies showcasing just the perfect blend of services. Visit us at the booth no 2861 – 3066. The SWISS Pavilion – a meeting place full of opportunities!
SWISS Pavilion
Switzerland at BIO 2025: Innovation, Collaboration, and Global Impact Welcome to the SWISS Pavilion at BIO International Convention 2025 – your gateway to one of the world’s most dynamic and resilient biotech ecosystems. Switzerland stands at the forefront of global biotechnology, driven by a unique blend of scientific excellence, international collaboration, and a deep commitment to innovation that benefits patients and partners worldwide. Switzerland’s biotech industry continues to demonstrate remarkable strength and adaptability. According to the Swiss Biotech Report 2025, the sector attracted CHF 2.5 billion in capital investment in 2024 – a 22% increase over the previous year – despite global economic headwinds. This growth reflects the confidence of international investors in Swiss innovation and the country’s ability to deliver breakthrough solutions in healthcare, diagnostics, and life sciences. With over 1,000 biotech companies and a dense network of academic institutions, research centers, and global pharma leaders, Switzerland offers a fertile environment for biotech innovation. The industry contributes significantly to the national economy, with life sciences accounting for over 50% of Swiss exports. This year’s Swiss Biotech Report emphasizes the importance of international collaboration. Four out of five biotech patents filed in Switzerland are the result of cross-border partnerships. Swiss companies are not only developing therapies for the local market – they are building global business cases, forming strategic alliances, and co-developing solutions that address some of the world’s most pressing health challenges. At the SWISS Pavilion, you’ll find a curated selection of Switzerland’s most promising biotech innovators – from agile startups and academic spin-offs to established scale-ups and research-driven SMEs. While each exhibitor brings a unique value proposition, together they represent the full spectrum of Swiss biotech excellence: – Next-generation therapeutics: From immuno-oncology to gene and cell therapies, Swiss companies are advancing novel treatment modalities with global potential. – Cutting-edge diagnostics: Precision medicine is a key focus, with technologies that enable earlier, more accurate, and personalized diagnosis. – Digital health and AI: Swiss innovators are integrating data science and machine learning into biotech workflows, accelerating discovery and improving patient outcomes. – Sustainable biomanufacturing: Several exhibitors are pioneering green biotech solutions and scalable production platforms. – Academic and regional clusters: The Pavilion also features representatives from Switzerland’s leading biotech hubs, including the Basel Area, the Greater Zurich Area, and Greater Geneva Bern area, showcasing the country’s decentralized yet interconnected innovation landscape. Why visit the SWISS Pavilion? – Meet high-potential partners: Engage with companies actively seeking international collaborations, licensing opportunities, and investment. – Explore innovation across the value chain: From early-stage research to clinical development and commercialization. – Experience Swiss quality and reliability: A hallmark of Swiss biotech is its commitment to scientific rigor, regulatory excellence, and long-term partnerships. Whether you’re looking for your next strategic partner, investment opportunity, or simply want to explore the future of biotech, the SWISS Pavilion is your destination at BIO 2025. Join us in shaping the future of global health – the Swiss way. | Switzerland at BIO 2026: Innovation, Collaboration, and Global Impact Welcome to the SWISS Pavilion at BIO International Convention 2026 – your gateway to one of the world’s most dynamic and resilient biotech ecosystems. Switzerland stands at the forefront of global biotechnology, driven by a unique blend of scientific excellence, international collaboration, and a deep commitment to innovation that benefits patients and partners worldwide. Switzerland’s biotech industry continues to demonstrate remarkable strength and adaptability. According to the Swiss Biotech Report 2025, the sector attracted CHF 2.5 billion in capital investment in 2024 – a 22% increase over the previous year – despite global economic headwinds. This growth reflects the confidence of international investors in Swiss innovation and the country’s ability to deliver breakthrough solutions in healthcare, diagnostics, and life sciences. With over 1,000 biotech companies and a dense network of academic institutions, research centers, and global pharma leaders, Switzerland offers a fertile environment for biotech innovation. The industry contributes significantly to the national economy, with life sciences accounting for over 50% of Swiss exports. This year’s Swiss Biotech Report emphasizes the importance of international collaboration. Four out of five biotech patents filed in Switzerland are the result of cross-border partnerships. Swiss companies are not only developing therapies for the local market – they are building global business cases, forming strategic alliances, and co-developing solutions that address some of the world’s most pressing health challenges. At the SWISS Pavilion, you’ll find a curated selection of Switzerland’s most promising biotech innovators – from agile startups and academic spin-offs to established scale-ups and research-driven SMEs. While each exhibitor brings a unique value proposition, together they represent the full spectrum of Swiss biotech excellence: – Next-generation therapeutics: From immuno-oncology to gene and cell therapies, Swiss companies are advancing novel treatment modalities with global potential. – Cutting-edge diagnostics: Precision medicine is a key focus, with technologies that enable earlier, more accurate, and personalized diagnosis. – Digital health and AI: Swiss innovators are integrating data science and machine learning into biotech workflows, accelerating discovery and improving patient outcomes. – Sustainable biomanufacturing: Several exhibitors are pioneering green biotech solutions and scalable production platforms. – Academic and regional clusters: The Pavilion also features representatives from Switzerland’s leading biotech hubs, including the Basel Area, the Greater Zurich Area, and Greater Geneva Bern area, showcasing the country’s decentralized yet interconnected innovation landscape. Why visit the SWISS Pavilion? – Meet high-potential partners: Engage with companies actively seeking international collaborations, licensing opportunities, and investment. – Explore innovation across the value chain: From early-stage research to clinical development and commercialization. – Experience Swiss quality and reliability: A hallmark of Swiss biotech is its commitment to scientific rigor, regulatory excellence, and long-term partnerships. Whether you’re looking for your next strategic partner, investment opportunity, or simply want to explore the future of biotech, the SWISS Pavilion is your destination at BIO 2026. Join us in shaping the future of global health – the Swiss way. | Swissenviro was founded in 2015 by Urs Heutschi. It is a small, privately-owned company and the organizer of the SWISS Pavilion at international trade fairs for environmental technologies. With more than 20 years of experience, the international fair work is our area of expertise and forms the core of our work. The aim is to support export-orientated Swiss Cleantech SME to find buyers and business partners in international markets by encouraging international networking and direct B2B contacts on trade fairs and other events. By participation in a Joint Swiss Booth, the “SWISS Pavillon”, we are bringing together Swiss SMEs with professional trade visitors – potential future buyers, partners or suppliers. If desired, we gladly accompany and support the SME further on its business project resulting from this first customer contact. We closely work together with relevant Swiss environmental associations such as Cleantech Alps, VSA and Energie-Cluster. For our SWISS Pavilions we are supported by the MPK from “Switzerland Global Enterprise” (S-GE) and the “Swiss Federal Office for the Environment” (FOEN).
Swiss Business Hub USA
The Swiss Business Hub USA is the New York-based representative of the official international trade and investment promotion agency Switzerland Global Enterprise (S-GE). Part of the Consulate General of Switzerland in New York and with offices in San Francisco, Atlanta and Boston (Cambridge), it is responsible for implementing Swiss export strategies in the US and for promoting Switzerland as a business location. The Swiss Business Hub USA provides localized support, market information, consulting and networking services to Swiss companies venturing into the US market. In addition, the Swiss Business Hub actively promotes Switzerland as a highly attractive business and investment location for US companies looking for growth in Switzerland and in Europe. The Swiss Business Hub proactively contacts and informs US-based companies about the key advantages of Switzerland as a business and investment location. The Swiss Business Hub USA has a first-rate network of contacts both in the US and in Switzerland. | The Swiss Business Hub USA is the New York-based representative of the official international trade and investment promotion agency Switzerland Global Enterprise (S-GE). Part of the Consulate General of Switzerland in New York and with offices in San Francisco, Atlanta and Boston (Cambridge), it is responsible for implementing Swiss export strategies in the US and for promoting Switzerland as a business location.
Swiss Biotech Association
Founded in 1998, the Swiss Biotech Association represents the interests of the Swiss biotech industry. To support its members in a competitive market, the Swiss Biotech Association works to secure favorable framework conditions and facilitate access to talents, novel technologies and financial resources. To strengthen and promote the Swiss biotech industry, the Swiss Biotech Association collaborates with numerous partners and life science clusters globally under the brand Swiss Biotech™.
State Of Iowa
Iowa’s bio-based economy encompasses development of industrial enzymes, livestock genetics, seed genetics, human gene research, nutraceuticals, pharmaceuticals, advanced bio-composites, biomass technologies and healthy foods/beverages. Iowa is home to global companies known for developing new plant hybrids for grains, leading genetics for beef and dairy production and many contributions to the rapid expansion of enzymes used for ethanol bioprocessing. Iowa is perfectly positioned with its central location and has a diversified and robust economy. Companies operating in Iowa benefit from a business-friendly state government, business-minded tax incentives and a skilled and productive workforce within a right-to-work state. The Iowa Economic Development Authority provides incentives, job training funding and confidential site selection services to businesses looking to locate or expand operations in the state of Iowa. For more information on Iowa’s business advantages, visit iowaeda.com. The Iowa Biotechnology Association (IowaBio) represents more than 100 members, which includes industry, academia and economic development organizations invested in Iowa’s biotech industry. From food and agricultural biotech, human and animal health, pharmaceutical research and development, to industrial and environmental innovation, sustainable biofuels and biochemical, enzyme and protein production, IowaBio’s diverse membership has a major impact in the state of Iowa and around the world. | Iowa is the #1 producer of eggs, red meat, pork and corn in the U.S., and home to global food industry leaders, startups and research institutions driving innovation. The state’s productive workforce, access to abundant raw ingredients, robust transportation infrastructure and low cost of doing business allow food and ag companies to thrive. Visit us at booth #A457 or connect with the Iowa Economic Development Authority to find the right resources to grow your business at iowaeda.com.
South Carolina Pavilion
SCbio is the definitive, unifying leader in South Carolina’s life sciences sector, fostering authentic collaboration and innovation across academia, startups, government and established enterprises. As a member-driven economic development organization, SCbio represents more than 1,000 organizations employing more than 87,000 professionals. Our members are unified by a mission to positively impact humanity through science across the ecosystem of advanced and specialty manufacturing; digital health and the data frontier; and cutting-edge health specializations. | South Carolina and its ambitious world class life sciences ecosystem provides a welcoming community for companies, scientific researchers and other organizations looking to blaze a new trail in the life sciences. From Advanced Biomanufacturing to Cutting Edge Health Specializations in Oncology and Neuroscience to leading solutions in Digital Health and Health Data, South Carolina is boldly shaping the future of science and the possibilities of life. South Carolina defies the status quo and provides a new model where science and life thrive in unison. SCbio is the definitive, unifying leader in South Carolina’s life sciences sector, fostering authentic collaboration and innovation across academia, startups, government and established enterprises. As a member-driven economic development organization, SCbio represents more than 1,000 organizations employing more than 87,000 professionals. Our members are unified by a mission to positively impact humanity through science across the ecosystem of advanced and specialty manufacturing; digital health and the data frontier; and cutting-edge health specializations.